CI2.F · Cantel Medical Corp

Cantel Medical Corp is currently in a long term uptrend where the price is trading 324.0% above its 200 day moving average.

From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.2.

Cantel Medical Corp's total revenue rose by 1.9% to $294M since the same quarter in the previous year.

Its net income has increased by 633.3% to $12M since the same quarter in the previous year.

Finally, its free cash flow grew by 51.6% to $36M since the same quarter in the previous year.

Based on the above factors, Cantel Medical Corp gets an overall score of 5/5.